1. Home
  2. ILMN vs CPAY Comparison

ILMN vs CPAY Comparison

Compare ILMN & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • CPAY
  • Stock Information
  • Founded
  • ILMN 1998
  • CPAY 1986
  • Country
  • ILMN United States
  • CPAY United States
  • Employees
  • ILMN N/A
  • CPAY N/A
  • Industry
  • ILMN Medical Specialities
  • CPAY EDP Services
  • Sector
  • ILMN Health Care
  • CPAY Technology
  • Exchange
  • ILMN Nasdaq
  • CPAY Nasdaq
  • Market Cap
  • ILMN 13.1B
  • CPAY 24.6B
  • IPO Year
  • ILMN 2000
  • CPAY 2010
  • Fundamental
  • Price
  • ILMN $98.15
  • CPAY $340.01
  • Analyst Decision
  • ILMN Buy
  • CPAY Buy
  • Analyst Count
  • ILMN 16
  • CPAY 14
  • Target Price
  • ILMN $126.88
  • CPAY $397.17
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • CPAY 480.7K
  • Earning Date
  • ILMN 08-05-2025
  • CPAY 08-06-2025
  • Dividend Yield
  • ILMN N/A
  • CPAY N/A
  • EPS Growth
  • ILMN N/A
  • CPAY 6.08
  • EPS
  • ILMN N/A
  • CPAY 14.26
  • Revenue
  • ILMN $4,337,000,000.00
  • CPAY $4,045,005,000.00
  • Revenue This Year
  • ILMN N/A
  • CPAY $13.37
  • Revenue Next Year
  • ILMN $3.11
  • CPAY $10.56
  • P/E Ratio
  • ILMN N/A
  • CPAY $23.80
  • Revenue Growth
  • ILMN N/A
  • CPAY 6.68
  • 52 Week Low
  • ILMN $68.70
  • CPAY $264.08
  • 52 Week High
  • ILMN $156.66
  • CPAY $400.81
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 77.43
  • CPAY 50.07
  • Support Level
  • ILMN $88.68
  • CPAY $320.80
  • Resistance Level
  • ILMN $95.99
  • CPAY $330.43
  • Average True Range (ATR)
  • ILMN 2.92
  • CPAY 9.36
  • MACD
  • ILMN 0.67
  • CPAY 0.00
  • Stochastic Oscillator
  • ILMN 86.09
  • CPAY 38.42

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About CPAY Corpay Inc.

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.

Share on Social Networks: